Cancer Communications-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2176940, encodeId=069721e69401e, content=请问Pending Editor Assignment多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d6fe5386329, createdName=Jojo, createdTime=Sun Dec 24 22:20:00 CST 2023, time=2023-12-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2205704, encodeId=291f2205e042f, content=Cancer Communication一审一个月的样子，目前修回，祈祷好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Mon May 20 15:57:23 CST 2024, time=2024-05-20, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2213265, encodeId=28962213265de, content=请问大家文章under review后几天有状态变化？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/V0jDcX4KLJG6rSBanWmltiaqj0U0MHMozLNm5Wick9JpJDPSk2SJ9Je00fic4tGZr471FM4dNurh5Ve4FIibv4yniaQ/132, createdBy=89552513701, createdName=lolllpoppy, createdTime=Thu Jul 04 20:50:37 CST 2024, time=2024-07-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211856, encodeId=face2211856db, content=这个期刊第一天就under review? 这是内部审核吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0eb5513755, createdName=罗, createdTime=Wed Jun 26 23:18:04 CST 2024, time=2024-06-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2206876, encodeId=4bde22068e62c, content=偏重的研究方向：肿瘤;癌症 经验分享：大佬们，没有under review 直接pending editor dicision是不是要被拒了？😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67dc9305536, createdName=ms1000001244935060, createdTime=Mon May 27 15:40:12 CST 2024, time=2024-05-27, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1239764, encodeId=83df1239e64d4, content=感觉是第二个molecular cancer, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a7845329653, createdName=148c7eccm12(暂无昵称), createdTime=Fri Aug 19 16:46:45 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127832, encodeId=423f212e83298, content=垃圾杂志找的什么破审稿人，审稿意见粗看言辞犀利细看狗屁不通，导致编辑直接给拒了，最离谱的就是指着一个EdU实验图说我IF染色分子定位不对，而且敲减组的荧光并没有显著减少。EdU还有别称叫IF吗？我文章里连IF都没提到过，能不能不要找连实验都没做过的人来审稿？别耽误人了行不行，简直离谱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18a58420111, createdName=ms6000001944827421, createdTime=Sun Apr 23 14:46:54 CST 2023, time=2023-04-23, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2183501, encodeId=498a21835014e, content=审稿好慢小修都快两个月有一样的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230618/9b2d932b46ee4a64beb72ae0d5e09357/4e66ffa5af414b5693f6683eb14c8bfb.jpg, createdBy=4c042515011, createdName=crgbjhffbnhfxc, createdTime=Tue Jan 23 20:47:54 CST 2024, time=2024-01-23, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2212565, encodeId=51c422125650e, content=刚投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb706489996, createdName=ms1000000123690393, createdTime=Mon Jul 01 10:21:37 CST 2024, time=2024-07-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1199064, encodeId=640a11990645f, content=10天了还在，initial checking......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11345587352, createdName=life2020hard, createdTime=Thu Mar 03 15:17:03 CST 2022, time=2022-03-03, status=1, ipAttribution=)]

2023-12-24 Jojo 来自北京

请问Pending Editor Assignment多久呀

137 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2176940, encodeId=069721e69401e, content=请问Pending Editor Assignment多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d6fe5386329, createdName=Jojo, createdTime=Sun Dec 24 22:20:00 CST 2023, time=2023-12-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2205704, encodeId=291f2205e042f, content=Cancer Communication一审一个月的样子，目前修回，祈祷好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Mon May 20 15:57:23 CST 2024, time=2024-05-20, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2213265, encodeId=28962213265de, content=请问大家文章under review后几天有状态变化？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/V0jDcX4KLJG6rSBanWmltiaqj0U0MHMozLNm5Wick9JpJDPSk2SJ9Je00fic4tGZr471FM4dNurh5Ve4FIibv4yniaQ/132, createdBy=89552513701, createdName=lolllpoppy, createdTime=Thu Jul 04 20:50:37 CST 2024, time=2024-07-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211856, encodeId=face2211856db, content=这个期刊第一天就under review? 这是内部审核吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0eb5513755, createdName=罗, createdTime=Wed Jun 26 23:18:04 CST 2024, time=2024-06-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2206876, encodeId=4bde22068e62c, content=偏重的研究方向：肿瘤;癌症 经验分享：大佬们，没有under review 直接pending editor dicision是不是要被拒了？😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67dc9305536, createdName=ms1000001244935060, createdTime=Mon May 27 15:40:12 CST 2024, time=2024-05-27, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1239764, encodeId=83df1239e64d4, content=感觉是第二个molecular cancer, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a7845329653, createdName=148c7eccm12(暂无昵称), createdTime=Fri Aug 19 16:46:45 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127832, encodeId=423f212e83298, content=垃圾杂志找的什么破审稿人，审稿意见粗看言辞犀利细看狗屁不通，导致编辑直接给拒了，最离谱的就是指着一个EdU实验图说我IF染色分子定位不对，而且敲减组的荧光并没有显著减少。EdU还有别称叫IF吗？我文章里连IF都没提到过，能不能不要找连实验都没做过的人来审稿？别耽误人了行不行，简直离谱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18a58420111, createdName=ms6000001944827421, createdTime=Sun Apr 23 14:46:54 CST 2023, time=2023-04-23, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2183501, encodeId=498a21835014e, content=审稿好慢小修都快两个月有一样的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230618/9b2d932b46ee4a64beb72ae0d5e09357/4e66ffa5af414b5693f6683eb14c8bfb.jpg, createdBy=4c042515011, createdName=crgbjhffbnhfxc, createdTime=Tue Jan 23 20:47:54 CST 2024, time=2024-01-23, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2212565, encodeId=51c422125650e, content=刚投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb706489996, createdName=ms1000000123690393, createdTime=Mon Jul 01 10:21:37 CST 2024, time=2024-07-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1199064, encodeId=640a11990645f, content=10天了还在，initial checking......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11345587352, createdName=life2020hard, createdTime=Thu Mar 03 15:17:03 CST 2022, time=2022-03-03, status=1, ipAttribution=)]

2024-05-20 H·D·E 来自重庆

Cancer Communication一审一个月的样子，目前修回，祈祷好结果

102 23

展开23条回复

[GetPortalCommentsPageByObjectIdResponse(id=2176940, encodeId=069721e69401e, content=请问Pending Editor Assignment多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d6fe5386329, createdName=Jojo, createdTime=Sun Dec 24 22:20:00 CST 2023, time=2023-12-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2205704, encodeId=291f2205e042f, content=Cancer Communication一审一个月的样子，目前修回，祈祷好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Mon May 20 15:57:23 CST 2024, time=2024-05-20, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2213265, encodeId=28962213265de, content=请问大家文章under review后几天有状态变化？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/V0jDcX4KLJG6rSBanWmltiaqj0U0MHMozLNm5Wick9JpJDPSk2SJ9Je00fic4tGZr471FM4dNurh5Ve4FIibv4yniaQ/132, createdBy=89552513701, createdName=lolllpoppy, createdTime=Thu Jul 04 20:50:37 CST 2024, time=2024-07-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211856, encodeId=face2211856db, content=这个期刊第一天就under review? 这是内部审核吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0eb5513755, createdName=罗, createdTime=Wed Jun 26 23:18:04 CST 2024, time=2024-06-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2206876, encodeId=4bde22068e62c, content=偏重的研究方向：肿瘤;癌症 经验分享：大佬们，没有under review 直接pending editor dicision是不是要被拒了？😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67dc9305536, createdName=ms1000001244935060, createdTime=Mon May 27 15:40:12 CST 2024, time=2024-05-27, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1239764, encodeId=83df1239e64d4, content=感觉是第二个molecular cancer, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a7845329653, createdName=148c7eccm12(暂无昵称), createdTime=Fri Aug 19 16:46:45 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127832, encodeId=423f212e83298, content=垃圾杂志找的什么破审稿人，审稿意见粗看言辞犀利细看狗屁不通，导致编辑直接给拒了，最离谱的就是指着一个EdU实验图说我IF染色分子定位不对，而且敲减组的荧光并没有显著减少。EdU还有别称叫IF吗？我文章里连IF都没提到过，能不能不要找连实验都没做过的人来审稿？别耽误人了行不行，简直离谱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18a58420111, createdName=ms6000001944827421, createdTime=Sun Apr 23 14:46:54 CST 2023, time=2023-04-23, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2183501, encodeId=498a21835014e, content=审稿好慢小修都快两个月有一样的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230618/9b2d932b46ee4a64beb72ae0d5e09357/4e66ffa5af414b5693f6683eb14c8bfb.jpg, createdBy=4c042515011, createdName=crgbjhffbnhfxc, createdTime=Tue Jan 23 20:47:54 CST 2024, time=2024-01-23, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2212565, encodeId=51c422125650e, content=刚投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb706489996, createdName=ms1000000123690393, createdTime=Mon Jul 01 10:21:37 CST 2024, time=2024-07-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1199064, encodeId=640a11990645f, content=10天了还在，initial checking......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11345587352, createdName=life2020hard, createdTime=Thu Mar 03 15:17:03 CST 2022, time=2022-03-03, status=1, ipAttribution=)]

2024-07-04 lolllpoppy 来自上海

请问大家文章under review后几天有状态变化？

107 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2176940, encodeId=069721e69401e, content=请问Pending Editor Assignment多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d6fe5386329, createdName=Jojo, createdTime=Sun Dec 24 22:20:00 CST 2023, time=2023-12-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2205704, encodeId=291f2205e042f, content=Cancer Communication一审一个月的样子，目前修回，祈祷好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Mon May 20 15:57:23 CST 2024, time=2024-05-20, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2213265, encodeId=28962213265de, content=请问大家文章under review后几天有状态变化？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/V0jDcX4KLJG6rSBanWmltiaqj0U0MHMozLNm5Wick9JpJDPSk2SJ9Je00fic4tGZr471FM4dNurh5Ve4FIibv4yniaQ/132, createdBy=89552513701, createdName=lolllpoppy, createdTime=Thu Jul 04 20:50:37 CST 2024, time=2024-07-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211856, encodeId=face2211856db, content=这个期刊第一天就under review? 这是内部审核吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0eb5513755, createdName=罗, createdTime=Wed Jun 26 23:18:04 CST 2024, time=2024-06-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2206876, encodeId=4bde22068e62c, content=偏重的研究方向：肿瘤;癌症 经验分享：大佬们，没有under review 直接pending editor dicision是不是要被拒了？😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67dc9305536, createdName=ms1000001244935060, createdTime=Mon May 27 15:40:12 CST 2024, time=2024-05-27, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1239764, encodeId=83df1239e64d4, content=感觉是第二个molecular cancer, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a7845329653, createdName=148c7eccm12(暂无昵称), createdTime=Fri Aug 19 16:46:45 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127832, encodeId=423f212e83298, content=垃圾杂志找的什么破审稿人，审稿意见粗看言辞犀利细看狗屁不通，导致编辑直接给拒了，最离谱的就是指着一个EdU实验图说我IF染色分子定位不对，而且敲减组的荧光并没有显著减少。EdU还有别称叫IF吗？我文章里连IF都没提到过，能不能不要找连实验都没做过的人来审稿？别耽误人了行不行，简直离谱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18a58420111, createdName=ms6000001944827421, createdTime=Sun Apr 23 14:46:54 CST 2023, time=2023-04-23, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2183501, encodeId=498a21835014e, content=审稿好慢小修都快两个月有一样的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230618/9b2d932b46ee4a64beb72ae0d5e09357/4e66ffa5af414b5693f6683eb14c8bfb.jpg, createdBy=4c042515011, createdName=crgbjhffbnhfxc, createdTime=Tue Jan 23 20:47:54 CST 2024, time=2024-01-23, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2212565, encodeId=51c422125650e, content=刚投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb706489996, createdName=ms1000000123690393, createdTime=Mon Jul 01 10:21:37 CST 2024, time=2024-07-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1199064, encodeId=640a11990645f, content=10天了还在，initial checking......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11345587352, createdName=life2020hard, createdTime=Thu Mar 03 15:17:03 CST 2022, time=2022-03-03, status=1, ipAttribution=)]

2024-06-26 罗来自北京

这个期刊第一天就under review? 这是内部审核吧

126 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2176940, encodeId=069721e69401e, content=请问Pending Editor Assignment多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d6fe5386329, createdName=Jojo, createdTime=Sun Dec 24 22:20:00 CST 2023, time=2023-12-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2205704, encodeId=291f2205e042f, content=Cancer Communication一审一个月的样子，目前修回，祈祷好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Mon May 20 15:57:23 CST 2024, time=2024-05-20, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2213265, encodeId=28962213265de, content=请问大家文章under review后几天有状态变化？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/V0jDcX4KLJG6rSBanWmltiaqj0U0MHMozLNm5Wick9JpJDPSk2SJ9Je00fic4tGZr471FM4dNurh5Ve4FIibv4yniaQ/132, createdBy=89552513701, createdName=lolllpoppy, createdTime=Thu Jul 04 20:50:37 CST 2024, time=2024-07-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211856, encodeId=face2211856db, content=这个期刊第一天就under review? 这是内部审核吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0eb5513755, createdName=罗, createdTime=Wed Jun 26 23:18:04 CST 2024, time=2024-06-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2206876, encodeId=4bde22068e62c, content=偏重的研究方向：肿瘤;癌症 经验分享：大佬们，没有under review 直接pending editor dicision是不是要被拒了？😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67dc9305536, createdName=ms1000001244935060, createdTime=Mon May 27 15:40:12 CST 2024, time=2024-05-27, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1239764, encodeId=83df1239e64d4, content=感觉是第二个molecular cancer, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a7845329653, createdName=148c7eccm12(暂无昵称), createdTime=Fri Aug 19 16:46:45 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127832, encodeId=423f212e83298, content=垃圾杂志找的什么破审稿人，审稿意见粗看言辞犀利细看狗屁不通，导致编辑直接给拒了，最离谱的就是指着一个EdU实验图说我IF染色分子定位不对，而且敲减组的荧光并没有显著减少。EdU还有别称叫IF吗？我文章里连IF都没提到过，能不能不要找连实验都没做过的人来审稿？别耽误人了行不行，简直离谱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18a58420111, createdName=ms6000001944827421, createdTime=Sun Apr 23 14:46:54 CST 2023, time=2023-04-23, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2183501, encodeId=498a21835014e, content=审稿好慢小修都快两个月有一样的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230618/9b2d932b46ee4a64beb72ae0d5e09357/4e66ffa5af414b5693f6683eb14c8bfb.jpg, createdBy=4c042515011, createdName=crgbjhffbnhfxc, createdTime=Tue Jan 23 20:47:54 CST 2024, time=2024-01-23, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2212565, encodeId=51c422125650e, content=刚投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb706489996, createdName=ms1000000123690393, createdTime=Mon Jul 01 10:21:37 CST 2024, time=2024-07-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1199064, encodeId=640a11990645f, content=10天了还在，initial checking......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11345587352, createdName=life2020hard, createdTime=Thu Mar 03 15:17:03 CST 2022, time=2022-03-03, status=1, ipAttribution=)]

2024-05-27 ms1000001244935060 来自辽宁省

偏重的研究方向：肿瘤;癌症
经验分享：大佬们，没有under review 直接pending editor dicision是不是要被拒了？😭

115 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2176940, encodeId=069721e69401e, content=请问Pending Editor Assignment多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d6fe5386329, createdName=Jojo, createdTime=Sun Dec 24 22:20:00 CST 2023, time=2023-12-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2205704, encodeId=291f2205e042f, content=Cancer Communication一审一个月的样子，目前修回，祈祷好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Mon May 20 15:57:23 CST 2024, time=2024-05-20, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2213265, encodeId=28962213265de, content=请问大家文章under review后几天有状态变化？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/V0jDcX4KLJG6rSBanWmltiaqj0U0MHMozLNm5Wick9JpJDPSk2SJ9Je00fic4tGZr471FM4dNurh5Ve4FIibv4yniaQ/132, createdBy=89552513701, createdName=lolllpoppy, createdTime=Thu Jul 04 20:50:37 CST 2024, time=2024-07-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211856, encodeId=face2211856db, content=这个期刊第一天就under review? 这是内部审核吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0eb5513755, createdName=罗, createdTime=Wed Jun 26 23:18:04 CST 2024, time=2024-06-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2206876, encodeId=4bde22068e62c, content=偏重的研究方向：肿瘤;癌症 经验分享：大佬们，没有under review 直接pending editor dicision是不是要被拒了？😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67dc9305536, createdName=ms1000001244935060, createdTime=Mon May 27 15:40:12 CST 2024, time=2024-05-27, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1239764, encodeId=83df1239e64d4, content=感觉是第二个molecular cancer, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a7845329653, createdName=148c7eccm12(暂无昵称), createdTime=Fri Aug 19 16:46:45 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127832, encodeId=423f212e83298, content=垃圾杂志找的什么破审稿人，审稿意见粗看言辞犀利细看狗屁不通，导致编辑直接给拒了，最离谱的就是指着一个EdU实验图说我IF染色分子定位不对，而且敲减组的荧光并没有显著减少。EdU还有别称叫IF吗？我文章里连IF都没提到过，能不能不要找连实验都没做过的人来审稿？别耽误人了行不行，简直离谱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18a58420111, createdName=ms6000001944827421, createdTime=Sun Apr 23 14:46:54 CST 2023, time=2023-04-23, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2183501, encodeId=498a21835014e, content=审稿好慢小修都快两个月有一样的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230618/9b2d932b46ee4a64beb72ae0d5e09357/4e66ffa5af414b5693f6683eb14c8bfb.jpg, createdBy=4c042515011, createdName=crgbjhffbnhfxc, createdTime=Tue Jan 23 20:47:54 CST 2024, time=2024-01-23, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2212565, encodeId=51c422125650e, content=刚投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb706489996, createdName=ms1000000123690393, createdTime=Mon Jul 01 10:21:37 CST 2024, time=2024-07-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1199064, encodeId=640a11990645f, content=10天了还在，initial checking......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11345587352, createdName=life2020hard, createdTime=Thu Mar 03 15:17:03 CST 2022, time=2022-03-03, status=1, ipAttribution=)]

2022-08-19 148c7eccm12(暂无昵称)

感觉是第二个molecular cancer

155 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2176940, encodeId=069721e69401e, content=请问Pending Editor Assignment多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d6fe5386329, createdName=Jojo, createdTime=Sun Dec 24 22:20:00 CST 2023, time=2023-12-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2205704, encodeId=291f2205e042f, content=Cancer Communication一审一个月的样子，目前修回，祈祷好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Mon May 20 15:57:23 CST 2024, time=2024-05-20, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2213265, encodeId=28962213265de, content=请问大家文章under review后几天有状态变化？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/V0jDcX4KLJG6rSBanWmltiaqj0U0MHMozLNm5Wick9JpJDPSk2SJ9Je00fic4tGZr471FM4dNurh5Ve4FIibv4yniaQ/132, createdBy=89552513701, createdName=lolllpoppy, createdTime=Thu Jul 04 20:50:37 CST 2024, time=2024-07-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211856, encodeId=face2211856db, content=这个期刊第一天就under review? 这是内部审核吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0eb5513755, createdName=罗, createdTime=Wed Jun 26 23:18:04 CST 2024, time=2024-06-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2206876, encodeId=4bde22068e62c, content=偏重的研究方向：肿瘤;癌症 经验分享：大佬们，没有under review 直接pending editor dicision是不是要被拒了？😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67dc9305536, createdName=ms1000001244935060, createdTime=Mon May 27 15:40:12 CST 2024, time=2024-05-27, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1239764, encodeId=83df1239e64d4, content=感觉是第二个molecular cancer, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a7845329653, createdName=148c7eccm12(暂无昵称), createdTime=Fri Aug 19 16:46:45 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127832, encodeId=423f212e83298, content=垃圾杂志找的什么破审稿人，审稿意见粗看言辞犀利细看狗屁不通，导致编辑直接给拒了，最离谱的就是指着一个EdU实验图说我IF染色分子定位不对，而且敲减组的荧光并没有显著减少。EdU还有别称叫IF吗？我文章里连IF都没提到过，能不能不要找连实验都没做过的人来审稿？别耽误人了行不行，简直离谱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18a58420111, createdName=ms6000001944827421, createdTime=Sun Apr 23 14:46:54 CST 2023, time=2023-04-23, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2183501, encodeId=498a21835014e, content=审稿好慢小修都快两个月有一样的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230618/9b2d932b46ee4a64beb72ae0d5e09357/4e66ffa5af414b5693f6683eb14c8bfb.jpg, createdBy=4c042515011, createdName=crgbjhffbnhfxc, createdTime=Tue Jan 23 20:47:54 CST 2024, time=2024-01-23, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2212565, encodeId=51c422125650e, content=刚投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb706489996, createdName=ms1000000123690393, createdTime=Mon Jul 01 10:21:37 CST 2024, time=2024-07-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1199064, encodeId=640a11990645f, content=10天了还在，initial checking......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11345587352, createdName=life2020hard, createdTime=Thu Mar 03 15:17:03 CST 2022, time=2022-03-03, status=1, ipAttribution=)]

2023-04-23 ms6000001944827421 来自上海

垃圾杂志找的什么破审稿人，审稿意见粗看言辞犀利细看狗屁不通，导致编辑直接给拒了，最离谱的就是指着一个EdU实验图说我IF染色分子定位不对，而且敲减组的荧光并没有显著减少。EdU还有别称叫IF吗？我文章里连IF都没提到过，能不能不要找连实验都没做过的人来审稿？别耽误人了行不行，简直离谱。

149 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2176940, encodeId=069721e69401e, content=请问Pending Editor Assignment多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d6fe5386329, createdName=Jojo, createdTime=Sun Dec 24 22:20:00 CST 2023, time=2023-12-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2205704, encodeId=291f2205e042f, content=Cancer Communication一审一个月的样子，目前修回，祈祷好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Mon May 20 15:57:23 CST 2024, time=2024-05-20, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2213265, encodeId=28962213265de, content=请问大家文章under review后几天有状态变化？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/V0jDcX4KLJG6rSBanWmltiaqj0U0MHMozLNm5Wick9JpJDPSk2SJ9Je00fic4tGZr471FM4dNurh5Ve4FIibv4yniaQ/132, createdBy=89552513701, createdName=lolllpoppy, createdTime=Thu Jul 04 20:50:37 CST 2024, time=2024-07-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211856, encodeId=face2211856db, content=这个期刊第一天就under review? 这是内部审核吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0eb5513755, createdName=罗, createdTime=Wed Jun 26 23:18:04 CST 2024, time=2024-06-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2206876, encodeId=4bde22068e62c, content=偏重的研究方向：肿瘤;癌症 经验分享：大佬们，没有under review 直接pending editor dicision是不是要被拒了？😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67dc9305536, createdName=ms1000001244935060, createdTime=Mon May 27 15:40:12 CST 2024, time=2024-05-27, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1239764, encodeId=83df1239e64d4, content=感觉是第二个molecular cancer, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a7845329653, createdName=148c7eccm12(暂无昵称), createdTime=Fri Aug 19 16:46:45 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127832, encodeId=423f212e83298, content=垃圾杂志找的什么破审稿人，审稿意见粗看言辞犀利细看狗屁不通，导致编辑直接给拒了，最离谱的就是指着一个EdU实验图说我IF染色分子定位不对，而且敲减组的荧光并没有显著减少。EdU还有别称叫IF吗？我文章里连IF都没提到过，能不能不要找连实验都没做过的人来审稿？别耽误人了行不行，简直离谱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18a58420111, createdName=ms6000001944827421, createdTime=Sun Apr 23 14:46:54 CST 2023, time=2023-04-23, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2183501, encodeId=498a21835014e, content=审稿好慢小修都快两个月有一样的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230618/9b2d932b46ee4a64beb72ae0d5e09357/4e66ffa5af414b5693f6683eb14c8bfb.jpg, createdBy=4c042515011, createdName=crgbjhffbnhfxc, createdTime=Tue Jan 23 20:47:54 CST 2024, time=2024-01-23, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2212565, encodeId=51c422125650e, content=刚投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb706489996, createdName=ms1000000123690393, createdTime=Mon Jul 01 10:21:37 CST 2024, time=2024-07-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1199064, encodeId=640a11990645f, content=10天了还在，initial checking......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11345587352, createdName=life2020hard, createdTime=Thu Mar 03 15:17:03 CST 2022, time=2022-03-03, status=1, ipAttribution=)]

2024-01-23 crgbjhffbnhfxc 来自湖北省

审稿好慢小修都快两个月有一样的吗

148 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2176940, encodeId=069721e69401e, content=请问Pending Editor Assignment多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d6fe5386329, createdName=Jojo, createdTime=Sun Dec 24 22:20:00 CST 2023, time=2023-12-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2205704, encodeId=291f2205e042f, content=Cancer Communication一审一个月的样子，目前修回，祈祷好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Mon May 20 15:57:23 CST 2024, time=2024-05-20, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2213265, encodeId=28962213265de, content=请问大家文章under review后几天有状态变化？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/V0jDcX4KLJG6rSBanWmltiaqj0U0MHMozLNm5Wick9JpJDPSk2SJ9Je00fic4tGZr471FM4dNurh5Ve4FIibv4yniaQ/132, createdBy=89552513701, createdName=lolllpoppy, createdTime=Thu Jul 04 20:50:37 CST 2024, time=2024-07-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211856, encodeId=face2211856db, content=这个期刊第一天就under review? 这是内部审核吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0eb5513755, createdName=罗, createdTime=Wed Jun 26 23:18:04 CST 2024, time=2024-06-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2206876, encodeId=4bde22068e62c, content=偏重的研究方向：肿瘤;癌症 经验分享：大佬们，没有under review 直接pending editor dicision是不是要被拒了？😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67dc9305536, createdName=ms1000001244935060, createdTime=Mon May 27 15:40:12 CST 2024, time=2024-05-27, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1239764, encodeId=83df1239e64d4, content=感觉是第二个molecular cancer, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a7845329653, createdName=148c7eccm12(暂无昵称), createdTime=Fri Aug 19 16:46:45 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127832, encodeId=423f212e83298, content=垃圾杂志找的什么破审稿人，审稿意见粗看言辞犀利细看狗屁不通，导致编辑直接给拒了，最离谱的就是指着一个EdU实验图说我IF染色分子定位不对，而且敲减组的荧光并没有显著减少。EdU还有别称叫IF吗？我文章里连IF都没提到过，能不能不要找连实验都没做过的人来审稿？别耽误人了行不行，简直离谱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18a58420111, createdName=ms6000001944827421, createdTime=Sun Apr 23 14:46:54 CST 2023, time=2023-04-23, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2183501, encodeId=498a21835014e, content=审稿好慢小修都快两个月有一样的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230618/9b2d932b46ee4a64beb72ae0d5e09357/4e66ffa5af414b5693f6683eb14c8bfb.jpg, createdBy=4c042515011, createdName=crgbjhffbnhfxc, createdTime=Tue Jan 23 20:47:54 CST 2024, time=2024-01-23, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2212565, encodeId=51c422125650e, content=刚投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb706489996, createdName=ms1000000123690393, createdTime=Mon Jul 01 10:21:37 CST 2024, time=2024-07-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1199064, encodeId=640a11990645f, content=10天了还在，initial checking......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11345587352, createdName=life2020hard, createdTime=Thu Mar 03 15:17:03 CST 2022, time=2022-03-03, status=1, ipAttribution=)]

2024-07-01 ms1000000123690393 来自广东省

刚投

112 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2176940, encodeId=069721e69401e, content=请问Pending Editor Assignment多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d6fe5386329, createdName=Jojo, createdTime=Sun Dec 24 22:20:00 CST 2023, time=2023-12-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2205704, encodeId=291f2205e042f, content=Cancer Communication一审一个月的样子，目前修回，祈祷好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Mon May 20 15:57:23 CST 2024, time=2024-05-20, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2213265, encodeId=28962213265de, content=请问大家文章under review后几天有状态变化？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/V0jDcX4KLJG6rSBanWmltiaqj0U0MHMozLNm5Wick9JpJDPSk2SJ9Je00fic4tGZr471FM4dNurh5Ve4FIibv4yniaQ/132, createdBy=89552513701, createdName=lolllpoppy, createdTime=Thu Jul 04 20:50:37 CST 2024, time=2024-07-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211856, encodeId=face2211856db, content=这个期刊第一天就under review? 这是内部审核吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0eb5513755, createdName=罗, createdTime=Wed Jun 26 23:18:04 CST 2024, time=2024-06-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2206876, encodeId=4bde22068e62c, content=偏重的研究方向：肿瘤;癌症 经验分享：大佬们，没有under review 直接pending editor dicision是不是要被拒了？😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67dc9305536, createdName=ms1000001244935060, createdTime=Mon May 27 15:40:12 CST 2024, time=2024-05-27, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1239764, encodeId=83df1239e64d4, content=感觉是第二个molecular cancer, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a7845329653, createdName=148c7eccm12(暂无昵称), createdTime=Fri Aug 19 16:46:45 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127832, encodeId=423f212e83298, content=垃圾杂志找的什么破审稿人，审稿意见粗看言辞犀利细看狗屁不通，导致编辑直接给拒了，最离谱的就是指着一个EdU实验图说我IF染色分子定位不对，而且敲减组的荧光并没有显著减少。EdU还有别称叫IF吗？我文章里连IF都没提到过，能不能不要找连实验都没做过的人来审稿？别耽误人了行不行，简直离谱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18a58420111, createdName=ms6000001944827421, createdTime=Sun Apr 23 14:46:54 CST 2023, time=2023-04-23, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2183501, encodeId=498a21835014e, content=审稿好慢小修都快两个月有一样的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230618/9b2d932b46ee4a64beb72ae0d5e09357/4e66ffa5af414b5693f6683eb14c8bfb.jpg, createdBy=4c042515011, createdName=crgbjhffbnhfxc, createdTime=Tue Jan 23 20:47:54 CST 2024, time=2024-01-23, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2212565, encodeId=51c422125650e, content=刚投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb706489996, createdName=ms1000000123690393, createdTime=Mon Jul 01 10:21:37 CST 2024, time=2024-07-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1199064, encodeId=640a11990645f, content=10天了还在，initial checking......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11345587352, createdName=life2020hard, createdTime=Thu Mar 03 15:17:03 CST 2022, time=2022-03-03, status=1, ipAttribution=)]

2022-03-03 life2020hard

10天了还在，initial checking.......

200 16

展开16条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务